Immediate Impact
15 by Nobel laureates 66 standout
Citing Papers
Traditional Chinese medicine in lung cancer treatment
2025 Standout
Cancer statistics, 2025
2025 Standout
Works of Joaquín Mosquera being referenced
Nivolumab + chemotherapy versus chemotherapy as neoadjuvant treatment for resectable stage IIIA NSCLC: Primary endpoint results of pathological complete response (pCR) from phase II NADIM II trial.
2022
10(th) Congress on Lung Cancer-updates on clinical trials: goal.
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Joaquín Mosquera | 304 | 226 | 71 | 39 | 441 | |
| Michèle Orain | 233 | 132 | 92 | 37 | 377 | |
| J. Crawford | 267 | 171 | 85 | 43 | 508 | |
| Vittorio Ferrari | 221 | 176 | 58 | 53 | 460 | |
| Matthew N. Mills | 192 | 222 | 93 | 46 | 398 | |
| J. Madelaine | 217 | 208 | 33 | 32 | 399 | |
| Jeremy Sharib | 222 | 127 | 63 | 24 | 387 | |
| Junichi Tomomatsu | 223 | 154 | 37 | 49 | 414 | |
| Ikuo Kamiyama | 183 | 184 | 73 | 29 | 402 | |
| Mitsumasa Kawago | 162 | 277 | 61 | 28 | 406 | |
| Nelly Firmin | 228 | 224 | 80 | 51 | 424 |
All Works
Login with ORCID to disown or claim papers
Loading papers...